Insider · CIK 0001383377

Dolecek Gayle R

Reports to the SEC for 1 company · BETHESDA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001383377

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-03-18	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,200 sh	$4.41	+$5,292	1,200
2014-03-18	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,200 sh	—	—	313,367
2014-03-18	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−1,200 sh	$8.03	−$9,636	0
2014-02-18	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−9,067 sh	$8.04	−$72.9K	0
2014-02-18	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,067 sh	$4.41	+$40K	9,067
2014-02-18	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,067 sh	—	—	314,567
2014-01-13	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,066 sh	$4.41	+$40K	9,066
2014-01-13	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,066 sh	—	—	323,634
2014-01-13	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−9,066 sh	$9.21	−$83.5K	0
2013-12-16	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−9,400 sh	$8.00	−$75.2K	377,700
2013-12-16	Sucampo Pharmaceuticals, Inc.X Exercise of In-Money	Director	XExercise of In-Money	−54.4K sh	$8.00	−$435K	332,700
2013-12-16	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)X Exercise of In-Money	Director	XExercise of In-Money	−45K sh	$8.00	−$360K	332,700
2011-05-02	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+57.6K sh	—	—	57,600
2011-05-02	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+113K sh	—	—	112,500
2010-01-15	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2007-12-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000

Recent filings

Accepted (ET)
Mar 214
Sucampo Pharmaceuticals, Inc.0001171843-14-001374
SEC(opens sec.gov)
Feb 214
Sucampo Pharmaceuticals, Inc.0001171843-14-000871
SEC(opens sec.gov)
Jan 234
Sucampo Pharmaceuticals, Inc.0001171843-14-000307
SEC(opens sec.gov)
Dec 184
Sucampo Pharmaceuticals, Inc.0001171843-13-005083
SEC(opens sec.gov)
May 164
Dolecek Gayle R0001144204-11-029665
SEC(opens sec.gov)
Jan 264
Dolecek Gayle R0001209191-10-004789
SEC(opens sec.gov)
Dec 194
Dolecek Gayle R0001209191-07-070883
SEC(opens sec.gov)

Companies

Sucampo Pharmaceuticals, Inc.Director

Address

4520 EAST-WEST HWY SUITE 300

BETHESDA, MD, 20814